DiaSorin receives clearance from US FDA for NxTAG panel
DiaSorin Spa announced Thursday that it has received 510k clearance from the U.S. Food and Drug Administration for the NxTAG Respiratory Pathogen Panel v2. This updated panel adds to Diasorin's...